Strohm Eric M, Callaghan Neal I, Ding Yu, Latifi Neda, Rafatian Naimeh, Funakoshi Shunsuke, Fernandes Ian, Reitz Cristine J, Di Paola Michelle, Gramolini Anthony O, Radisic Milica, Keller Gordon, Kolios Michael C, Simmons Craig A
Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, M5S 3G8, Canada.
Translational Biology and Engineering Program, Ted Rogers Center for Heart Research, Toronto, M5G 1M1, Canada.
ACS Nano. 2024 Jan 9;18(1):314-327. doi: 10.1021/acsnano.3c06325. Epub 2023 Dec 26.
Cell-based models that mimic in vivo heart physiology are poised to make significant advances in cardiac disease modeling and drug discovery. In these systems, cardiomyocyte (CM) contractility is an important functional metric, but current measurement methods are inaccurate and low-throughput or require complex setups. To address this need, we developed a standalone noninvasive, label-free ultrasound technique operating at 40-200 MHz to measure the contractile kinetics of cardiac models, ranging from single adult CMs to 3D microtissue constructs in standard cell culture formats. The high temporal resolution of 1000 fps resolved the beat profile of single mouse CMs paced at up to 9 Hz, revealing limitations of lower speed optical based measurements to resolve beat kinetics or characterize aberrant beats. Coupling of ultrasound with traction force microscopy enabled the measurement of the CM longitudinal modulus and facile estimation of adult mouse CM contractile forces of 2.34 ± 1.40 μN, comparable to more complex measurement techniques. Similarly, the beat rate, rhythm, and drug responses of CM spheroid and microtissue models were measured, including in configurations without optical access. In conclusion, ultrasound can be used for the rapid characterization of CM contractile function in a wide range of commonly studied configurations ranging from single cells to 3D tissue constructs using standard well plates and custom microdevices, with applications in cardiac drug discovery and cardiotoxicity evaluation.
模拟体内心脏生理学的细胞模型有望在心脏病建模和药物发现方面取得重大进展。在这些系统中,心肌细胞(CM)的收缩性是一个重要的功能指标,但目前的测量方法不准确、通量低,或者需要复杂的设置。为满足这一需求,我们开发了一种独立的非侵入性、无标记超声技术,工作频率为40-200MHz,用于测量心脏模型的收缩动力学,范围从单个成年心肌细胞到标准细胞培养形式的3D微组织构建体。1000帧/秒的高时间分辨率解析了以高达9Hz起搏的单个小鼠心肌细胞的搏动轮廓,揭示了基于较低速度光学测量在解析搏动动力学或表征异常搏动方面的局限性。超声与牵引力显微镜的结合能够测量心肌细胞的纵向模量,并轻松估算成年小鼠心肌细胞2.34±1.40μN的收缩力,这与更复杂的测量技术相当。同样,测量了心肌球状体和微组织模型的搏动频率、节律和药物反应,包括在没有光学通道的配置中。总之,超声可用于快速表征从单细胞到3D组织构建体等广泛常见研究配置中心肌细胞的收缩功能,这些配置使用标准孔板和定制微器件,在心脏药物发现和心脏毒性评估中有应用。